Catalyst
Slingshot members are tracking this event:
Amicus Therapeutics (FOLD) to complete evaluation of RBCx (Red Blood Cell Exchange) system in patients with sickle cell disease in January 2018
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| FOLD |
|
|
||||
Additional Information
Slingshot Insights Explained
Catalyst Date
Occurred on:
Jan 19, 2018
Occurred Source:
https://clinicaltrials.gov/ct2/show/NCT02372877?term=amicus&rank=1&submit_fld_opt=
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Sickle Cell Disease, Rbcx, Red Blood Cell Exchange, Phase 1/2, Open-label
